• Nenhum resultado encontrado

Enteric parasites and AIDS

N/A
N/A
Protected

Academic year: 2017

Share "Enteric parasites and AIDS"

Copied!
8
0
0

Texto

(1)

INTRODUCTION

Since the first AIDS cases were described, a high prevalence o f gastro intestinal alteratio ns has been repo rted, especially diarrhea asso ciated with parasito sis.

This b e c a me mo re e vid e nt w he n the appearance o f a syndro me named “Slim Disease”, c ha ra c te riz e d b y a n inte nse w e ig ht lo ss accompanied by chronic diarrhea, prolonged fever and diffuse muscle weakness, was o bserved in Africa, especially in Uganda.1 ,2 ,3 Studies conducted in Zaire and Uganda have sho wn the presence o f so me patho genic agents respo nsible fo r the “ Slim Disease” , such as Iso spo ra, Crypto spo ridium, Salmo nella, Shigella and Campylo bacter species, amo unting to a prevalence o f 6 0 to 8 0 %.4 “ Slim Disease” has been o bserved in advanced stages o f HIV infe c tio n. The e xp re ssio n “ W a sting Syndro me” was ado pted in substitutio n by W HO in 1 9 8 8 o n the basis o f criteria laid do wn by the CDC.2

Thus, where as infections in the gastrointestinal tract play a critical ro le in AIDS patho genesis and dia rrhe ic dise a se s a ssume a pro mine nt ro le , re a c hing a ra te o f up to 5 0 % in de ve lo pe d co untries, in develo ping co untries there have been repo rts o f incidence o f up to 9 5 %, as in Haiti and

R eview A rticle

Ente ric parasite s and AIDS

Instituto de Infectologia Emílio Ribas and Univerisidade Federal de São Paulo/

Escola Paulista de Medicina, São Paulo, Brazil

Sérgio Cimerman Benjamin Cimerman David Salomão Lewi

ABSTRACT

O BJECTIVE: To repo rt o n the impo rtance o f intestinal parasites in patients with AIDS, sho wing relevant data in the medical literature, with special emphasis o n

epidemio lo g y, diag no sis and treatment o f entero parasito sis, especially crypto spo ridiasis, iso spo riasis, micro spo ridiasis and stro ng ylo idiasis.

DESIGN : N arrative review.

(2)

the African co ntinent.5

Amongst the causes of diarrhea in developing co untries, tho se o f a parasitic o rigin are pro minent in patients with AIDS.

O ppo rtunistic infectio ns caused by intestinal parasites also vary acco rding to the geo graphical area and the endemic levels in each lo catio n.

The progressive decline of immunological and muco us defense mechanisms predispo ses patients to early, intermediary and late g astro intestinal manifestatio ns o f HIV infectio n.6 At later stages o f the disease, the alteratio ns in no n-specific defense mechanisms in the pro ductio n o f Ig A and the reduc tio n in lo c a l immune c ell respo nse a lso pro g ress, thus increasing the susceptibility to a numb er o f intestina l o ppo rtunistic pa tho g ens, amo ng which Crypto spo ridium parvum, Iso spo ra belli and Micro spo ridia species are the mo st pro minent.7

After the emergence o f AIDS, these parasites, until then known solely in veterinary medicine, were no longer considered as commensal organisms and a re no w a d a ys re c o g niz e d a s o p p o rtunistic patho gens co mmo n to these patients. Infectio ns by these ag ents co nstitute a majo r seco ndary aggravating facto r o f the disease, o ften respo nsible fo r wo rsening the general health co nditio ns, due to manifestatio ns o f diarrhea which are difficult to co ntro l, so metimes resulting in the death o f the patient.

CRYPTOSPORIDIASIS

Crypto spo ridiasis, a disease caused by an intracellular protozoan named Cryptosporidium sp, was described fo r the first time in 1 9 0 7 by Tyzzer. This parasite was co nsidered a co mmensal up to 1 9 7 5 , when it was identified as the cause o f diarrhea in animals.8

The first manifestatio n o f crypto spo ridiasis was repo rted by N ine et al. in 1 9 7 6 , and the d ise a se b e c a me a ma jo r c o nc e rn w he n the no tificatio n o f the first 2 1 patients was given, 1 4 o f who m died o f chro nic diarrhea caused by Crypto spo ridium sp infectio n.9

It is worth noting that outbreaks of epidemic linked to c o nta mina ted wa ter a re o f extreme

importance for the dissemination of this parasite such as the 1 9 9 3 Milwaukee (USA) crypto spo ridiasis o utbreak, in which 4 0 3 ,0 0 0 human cases were reported, thereby becoming a relevant public health concern.10-12 After this outbreak, it was recommended tha t immuno c o mpro mise d pa tie nts sho uld b e extremely careful with water, foodstuffs and contact with animals.

Crypto spo ridia sis is distrib ute d o ve r a ll continents. In Haiti and the African continent the prevalence is 50%,13 while in the USA it ranges from 3 to 4%.14

In Brazil, due to the co ntinental size o f the country, the rates of incidence vary with the location. In the city o f São Paulo , fo r instance, repo rts have referred to levels aro und 1 2 .1 to 2 4 .4 4 %.1 5 -1 7 Ho wever, the latest epidemio lo g ical repo rt o n Bra z il, d a te d Fe b rua ry 1 9 9 8 , sho w s a crypto spo ridiasis rate o f o nly 3 .5 %.1 8

Crypto spo ridiasis in AIDS patients usually causes chronic, bulky and intermittent diarrhea, with liquid non-bloody stools, accompanied by pain and abdo minal co lic, and a no ticeable lo ss o f weight can be o bserved.8

Asympto matic cases are rarely described, o ccurring mo stly in develo ping co untries with patients sho wing milder immuno deficiency.1 9 ,2 0

Extra intestina l ma nifesta tio ns ha ve b een clearly described in the literature, especially in the gall bladder, biliary ducts and pancreas, leading to co nditio ns such as papillary steno sis, sclero sing c ho la ng itis a nd a c a lc ulo us c ho le c ystitis. The re sp ira to ry tra c t c a n a lso b e a ffe c te d w ith manifestatio ns o f chro nic bro nchitis.2 1 ,2 2

The intensity and duratio n o f diarrhea in crypto spo ridio sis cases is clo sely asso ciated with the CD4 + T cell co unts. This is well demo nstrated in a classic study on HIV-infected patients with CD4+ cell co unts higher than 1 8 0 / mm3 who displayed clinical healing o ver a perio d o f fo ur weeks, while 8 7 % o f the pa tie nts pre se nting mo re se ve re immuno suppressio n, with CD4 + co unts lo wer than 1 4 0 / mm3, presented persistent and hard-to -co ntro l diarrhea.2 3

(3)

Neelsen) and auramine-rho damine metho ds, via the detectio n o f reddish-stained Crypto spo ridium oocysts.2 4 More sophisticated diagnostic techniques using monoclonal antibodies are already available, such as ELISA and immuno fluo rescence, with high sensitivity and specificity.2 5 -2 7 The treatment is co ntro versial, with rehydratio n via an appro priate liquid balance and the maintenance o f the patient’s nutritio nal co nditio n being reco mmended. There sho uld be careful mo nito ring and administratio n o f antidiarrheic drug s when needed.2 8 Several treatments are available but they have no t sho wn significant clinical efficiency. Studies have been co nducted with hyperimmune bo vine co lo strum, letrazuril and diclazuril (veterinary medicine drugs), spira mic yn a nd mo re re c e ntly a z ithro mic yn, paro mo mycin, o ctreo tide and ro xithro mycin.2 9 -3 1

ISOSPORIASIS

Iso spo ra belli is a co ccidium described fo r the first time in 1 9 1 5 by W o o dco ck and later by W enyo n in 1 9 2 3 .3 2 It is fo und in tro pical and subtropical areas and is endemic in South America, Africa and in So uthern Asia,3 3 with an o ccurrence rate o f 1 5 % in Haiti,3 3 0 .2 % in the USA3 4 and 1 .8 % in Brazil.1 8

Higher rates o f iso spo riasis in Brazil have been repo rted in AIDS patients living in Santo s and in São Paulo , with a prevalence o f 9 .9 % and 6 .6 7 %, respectively.1 7 ,3 5 The lo wer prevalence o f Iso spo riasis may be ascribed to the seco ndary p ro p hyla xis fo r p ne umo c ysto sis thro ug h administratio n o f sulfametho xazo le-trimetho prim during the co urse o f AIDS, since Iso spo ra belli is sensitive to this therapy.3 6

The diarrheic co nditio n is also no tewo rthy and is acco mpanied by fever, intestinal co lic, ano rexia, abdo minal pain, lo ss o f weig ht and peripheral eo sino philia.3 7

Iso spo riasis can also sho w extraintestinal disseminatio n features, affecting the mesenteric, periaortic, mediastinal and tracheobronchial lymph no des.3 8 ,3 9 It may also be related to biliary disease, causing manifestatio ns o f acalculo us cho lecystitis.3 7 Iso spo ra belli differs mo rpho lo gically fro m Crypto spo ridium sp no t o nly because o f its intrinsic

mo rpho lo gy (elliptical o o cyst measuring 2 2 x 1 5 µm in diameter, co ntaining two spo ro cysts with fo ur spo ro zo o ites), but also fo r the intracellular lo catio n in the abso rptive cell, while Crypto spo ridium is restricted to the brush bo rders, immediately under the apical membrane o f abso rptive cells.4 0

Labo rato ry diagno sis is carried o ut in the same way as fo r Crypto spo ridium parvum, using the Kinyoun and auramine-rhodamine techniques,4 1 altho ugh co mmo n pro cesses such as Faust’s are o fte n e no ug h fo r the dia g no sis. The spe c ia l c o lo ra tio n thus b ec o mes a further dia g no stic element fo r finding the parasite.

The the ra p e utic re c o mme nd a tio n fo r iso sp o ria sis is the a d ministra tio n o f sulfa me tho xa z o le -trime tho p rim fo r 1 0 d a ys, fo llo wed by pro phylaxis fo r a further three weeks. This le a d s to a re d uc tio n in the numb e r o f discharg es and the reco very o f bo dy weig ht.3 6 In re c urre nt situa tio ns o r in no n-re sp o nd ing patients it is necessary to administer o ther drug s suc h a s p yrime tha mine , in iso la tio n o r in asso ciatio n with sulfadiaz ine,4 2 ro xithro mycin4 3 and metro nidazo le.4 4 Drug s such as tetracycline, a mp ic illin, nitro fura nto in, q uina c rine a nd furazo lido ne have already been used but sho wed no therapeutic success.3 4

MICROSPORIDIASIS

The third majo r gro up o f intestinal patho gens to be repo rted are the micro spo ridia, which are strictly intracellular pro to zo a, spo re-pro ducing and with great variety of genera and species. They have widespread distributio n and o ver 4 0 0 cases o f patients with co -infectio n o f micro spo ridia and HIV have been repo rted. The majo r etio lo gic agent is Entero cyto zo o n bieneusi.4 5

The first d e sc rip tio n o f inte stina l mic ro sp o rid ia sis in a n HIV-p o sitive p a tie nt o ccurred in France.4 6 The first descriptio n o f this co nditio n in Braz il dates back to 1 9 9 3 , with cases having o ccurring in Rio de Janeiro , São Paulo and Ceará.4 7 -5 0

(4)

technique fo r detectio n o f micro spo ridian spo res in the sto o l samples o f 1 4 0 HIV-po sitive patients sho wed that the rate o f prevalence o f intestinal micro spo ridiasis was 1 7 .8 6 %.5 2 The fact that these c a se s ha ve o nly re c e ntly a p p e a re d c a n b e explained by the diagno stic difficulty, as electro nic micro sco py is required fo r co nfirmatio n o f the presence o f the parasite. In co ntrast, in the city o f São Paulo only 1.3% of microsporidian spores were sho wn up in pa tients with AIDS a nd c hro nic dia rrhe a via the mo difie d tric hro me sta ining metho d.5 2 A

O ptical micro sco py metho ds, such as the chromotrope method, were then proposed whereby spo res wo uld appear as o val-shaped and stained pink o r pa le re d.5 3 This te c hniq ue ha s b e e n impro ved and named G ram-chro mo tro pe. Fecal sample smears are stained in G ram’s stain, followed by a chro mo tro pe so lutio n.5 4

Chro nic diarrhea and/ o r biliary disease manifestatio ns in HIV-infected individuals with CD4 + T cells o f between 5 0 and 1 0 0 / mm3 may suggest micro spo ridio sis. Transmissio n is unkno wn to date, but there have been repo rts o f co ngenital tra nsmissio n a nd via inha la tio n o f a irb o rne spo res.5 1

Regarding treatment, albendazo le has been the mo st pro mising drug fo r handling intestinal micro spo ridiasis. 5 5 -5 7

GIARDIASIS AND AMEBIASIS

The p ro to z o a ns G ia rd ia la mb lia a nd Entamoeba histolytica are important causes of acute diarrhea in ho mo sexual males, even fo r tho se that are no t HIV-po sitive. To gether with Campylo bacter, Salmo nella, Shiguella and Yersinia they cause high frequencies o f enteritis, co litis and pro ctitis.5 8

Statistical data fo und in the literature are ra the r d ive rg e nt, b ut the inc id e nc e o f the se pro to zo ans amo ngst the ho mo sexual po pulatio ns o f large cities, such as New Yo rk, Lo s Angeles, San Francisco and To ro nto is quite high.5 9

The prevalence o f Entamo eba histo lytica in HIV-neg ative ho mo sexual patients in the USA ranges between 2 1 and 3 2 %, and is aro und 1 2 % in the United Kingdo m.6 0

A study perfo rmed in Lo s Angeles with 1 0 0 HIV-po sitive patients, mo stly ho mo sexuals, sho wed a prevalence rate o f 5 5 % fo r giardiasis and 3 % fo r amo ebiasis.6 1

In Fra nc e , stud ie s fo c use d up o n the prevalence o f intestinal parasito sis sho wed a high frequency o f pro to zo an species in AIDS patients, and the rates o f G iardia lamblia and Entamo eba histo lytica were 5 .8 % and 2 %, respectively 6 2.

Previo us studies demo nstrated that giardiasis incidence do es no t differ amo ngst HIV-po sitive and negative patient po pulatio ns.6 3

Infec tio n with G ia rdia la mb lia a nd HIV amo ng st ho mo sexual males is co rrelated with enteritis o r entero co litis, but no histo lo gical study o f the co lo nic muco sa has yet been carried o ut.6 4 In Brazil, examinatio n o f 7 7 1 fecal samples fro m AIDS patients living in São Paulo , perfo rmed under the pro gram fo r the co ntro l and preventio n o f AIDS, have sho wn rates o f 5 .1 8 % and 8 .4 9 % o f amebiasis and giardiasis, respectively.1 5 In a recent study in the city o f São Paulo analyzing patients with mo re severe immuno deficiency, E. histo lytica was no t o bserved but G . lamblia cysts were seen in about 2 7 % of the examined patients.1 7 De sp ite this hig h p re va le nc e , c la ssic a l pro to zo a such as G iardia Lamblia and Entamo eba histo lytica are less frequent as causes o f severe illnesses in HIV-infected patients, when co mpared w ith M ic ro sp o rid ia , Iso sp o ra b e lli a nd C ryp to sp o rid ium p a rvum a nd the y a re no t co nsidered as o ppo rtunistic infectio ns in AIDS.

A me b ia sis ma y p re se nt w ith inva sive characteristics, but this has rarely been repo rted in the literature.6 5

Mo re re c e ntly, in Re c ife , a stud y w a s co nducted to evaluate invasive amebiasis in AIDS patients. Seventy fo ur patients were examined, o ut of which 54 had diarrhea but Entamoeba histolytica was found in only one patient (1,3%) and practically an absence o f invasive amo ebiasis.6 6

STRONGYLOIDIASIS

(5)

first described in 1 8 7 6 by Normand, after necropsy o f patients with diarrhea in fro m Co chin-China, then an auto no mo us regio n o f China.6 7

This geo helminth presents its majo r effects in immuno d e p re sse d p a tie nts, le a d ing to the dissemina tio n o f the infec tio n. This o c c urs in tra nspla nte d pa tie nts, individua ls pre se nting malnutritio n and patients submitted to pro lo nged use o f co rtico stero ids, suffering fro m leukemia, lympho mas o r AIDS.6 8 ,6 9

Despite the po ssibility o f disseminatio n o f this helminth in HIV-po sitive patients, o nly 1 4 cases had b e e n re po rte d b y 1 9 9 4 in the inte rna tio na l literature.7 0

A case o f massive infectio n by Stro ngylo ides sterco ralis in AIDS patients in São Paulo was recently repo rted, presenting the nemato de even in sputum samples.7 1

The c linic a l synd ro me o f d isse mina te d stro ngylo idiasis is characterized by gastro intestinal signs and sympto ms, such as nausea, vo miting, meteo rism, ano rexia and diarrhea, alternating with perio ds o f intestinal co nstipatio n and seco ndary infectio ns. Respirato ry sympto ms such as dyspnea, hemo ptysis, co ughing, o r manifestatio ns o f asthma and even extensive pneumo nia, may be o bserved. At the same time, the patient can present fever, cachexia and lo ss o f weight.7 2 , 7 3

In immuno suppressed patients, self-infestatio n is speeded up and a large number o f larvae are re le a se d , c a using the d isse mina tio n o f the infectio n.7 4

In Brazil, the prevalence o f stro ngylo idiasis in HIV-po sitive patients is aro und 4 to 1 5 %, in c o mp a riso n w ith 1 . 4 % in the g e ne ra l po pulatio n.1 5 ,1 7 ,6 9

Labo rato ry diag no sis is based upo n the Baerman-Mo raes o r Rugai-Matto s-Briso la metho ds, presenting as their basic principle the thermo and hydro tro pism o f Stro ngylo ides sterco ralis larvae seen in sto o l samples.6 7

Stro ngylo ides sterco ralis larvae may also be detected in aspirated duo denal material, sputum, bro ncho -alveo lar lavage, cervico vaginal cyto lo gy, cerebro spinal fluid and gastric cyto lo gy.7 4

G e ne ra lly, the se a rc h fo r Stro ng ylo ide s sterco ralis, even in iso lated samples, sho ws a

p o sitivity o f 3 0 % in immuno c o mp ro mise d individuals with AIDS. W hen three or more samples are taken, this po sitivity reaches levels as high as 8 0 %.6 7

Thia b enda z o le is c o nsidered the drug o f c ho ic e fo r tre a ting stro ng y lo id ia sis, in immuno sup p re sse d ind ivid ua ls. The ra te s o f eradicatio n by this anti-helminth drug can reach le ve ls a s hig h a s 9 0 % .6 7 , 6 8 , 7 2 O the r c hemo thera py a g ents tha t ma y b e used inc lude a lb enda z o le a nd c a mb enda z o le.

In Stro ng ylo ides sterco ralis hyperinfectio n cases, treatment with thiabendazo le may be used fo r pro lo nged perio ds, fo llo wed by maintenance do ses. O ften, eradicatio n is difficult.7 0 ,7 1 Ano ther o ptio n in these cases is the administratio n o f ivermectin, a drug used fo r o ncho cerciasis, with healing rates aro und 9 4 %.7 0 ,7 5 ,7 6 This drug is no t yet available in Brazil.

OTHER PARASITES

O ther helminths such as Ascaris lumbricoides (3.52%), Trichiuris trichiura (4.14%), Ancylostomidae (2 . 6 9 % ), Ente ro b ius ve rmic ula ris (0 . 2 1 % ), Schistosoma mansoni (1 .6 6 %), Taenia sp (0 .2 1 %) and Hymenolepis nana (10.41%) have shown lesser frequency and importance in AIDS patients.1 5

Several o ther intestinal parasito ses may lead to aggravatio n and/ o r disseminatio n o f the co urse o f AIDS. Pro to zo a such as Cyclo spo ra sp and Blasto cystis ho minis have arisen, which may also cause majo r diarrhea manifestatio ns.

Bla sto c ystis ho minis is a p o te ntia lly patho genic parasite, mo re predo minant in male ho mo sexuals than in o ther po pulatio n gro ups, and its o ccurrence is no t higher in individuals suffering fro m digestive disturbances.7 7 It has been iso lated in human feces with a frequency ranging fro m 1 to 6 0 % in individuals fro m different parts o f the wo rld and expo sure to co ntaminated water co ntributes to the increase o f this parasito sis.7 8

(6)

were recently repo rted with parasite eradicatio n in the sto o l samples after specific treatment.8 1

Bla sto c ystis infe c tio n is c o mmo n in immunocompromised hosts and it may be diagnosed through conventional techniques such as the Lutz and Faust methods. There are reports in the literature that show trichrome stains and Ficol concentrations as alternatives for finding this parasite.8 2 ,8 3

The re is so me c o ntro ve rsy a b o ut the appro priateness o f treating this entero parasito sis. W hen treatment is chosen, metronidazole is used.8 4 Cyclo spo ra sp was initially iso lated in 1 8 7 0 by Eimer. The first repo rt o n its asso ciatio n with AIDS dates back to March 1 9 8 9 , in a male patient with chro nic diarrhea.8 5

Studies o n the prevalence o f cyclo spo riasis sho w very lo w ra tes, no t hig her tha n 1 % in develo ped co untries.8 6 ,8 7

O utb re a ks o f c yc lo spo ria sis due to the c o nsump tio n o f ra sp b e rrie s imp o rte d fro m G uatemala o ccurred recently: 1 4 6 5 cases were repo rted fro m 2 0 sta tes o f the USA.8 8 O ther o utbreaks were repo rted in Virginia (USA), due to contamination of fresh basil, causing gastrointestinal disease.8 9

The diag no sis o f infectio n by Cyclo spo ra cayatenensis is based upo n the detectio n o f o o cysts in fe c a l sa mp le s, via o p tic a l mic ro sc o p y. C yc lo sp o ra c a ya te ne nsis d iffe rs fro m Crypto spo ridium in its larg e size.9 0 Due to the mo rpho lo gical similarities and lack o f kno wledge o n ho w to differentiate between these two species, d ia g no sis o f c yc lo sp o rid io sis is se ld o m acco mplished.3 3 It is essential to determine the spo rulatio n o f Cyclo spo ra, which may be do ne using 2 .5 % po tassium dichro mate.

The low frequency of this protozoan may once again be explained by the use o f sulfametho xazo le-trimetho prim administratio n as a pro phylactic treatment ag ainst Pneumo cystis carinii in AIDS patients presenting CD4 + cell co unts lo wer than 2 0 0 / mm3.9 1 ,9 2

CONCLUSION

It can be no ted that parasito sis presents a very significant interface with AIDS, and this has b een the o b jec t o f studies b y ma ny a utho rs.

Investigatio ns o n the etio lo gy o f diarrhea in HIV-infected patients indicate parasito sis as the cause in up to 4 0 % o f patients.

REFERENCES

1. Kanradt T, Niese D, Vo gel F. Slim disease (AIDS). Lancet 1985;2:1425. 2. Mhiri C, Bélec L, Di Co nstanzo B, et al. The slim disease in African

patients with AIDS. Trans R So c Tro p Med Hyg 1992;86:303-6. 3. Grunfeld C, Schanbelan M. The wasting syndro me: patho physio lo gy

and treatment. In: Bro der S, Merigan Jr TC, Bo lo gnesi D. Textbo o k o f Aids Medicine. 2nd ed. New Yo rk: Williams & Williams; 1994:637-49. 4. Bo linger RC, Quinn TC. Tro pical diseases in the HIV-infected traveler.

In: Bro der S, Merigan Jr, Bo lo gnesi D. Textbo o k o f Aids Medicine, 2ed. New Yo rk: Williams & Williams; 1994:311-22.

5. Sm ith PD. Diarré ia infe c c io sa no s p ac ie nte s c o m AIDS. Clin Gastro entero l Am No rte 1993;3:569-84.

6. McGo wan I, Chalmers A, Smith GR, Jewell D. Advances in muco sal immuno lo gy. Gastro entero l Clin No rth Am 1997;26:145-73.

7. So ares RLS, Camillo -Co ura L, Magalhães LF, et al. Iso spo ríase co mo causa freqüente de diarréia crô nica em pacientes co m AIDS em no sso meio . Ann Acad Nac Med 1996;156:24-5.

8. So ave R, Armstro ng D. Crypto spo ridium and crypto spo ridio sis. Rev Infect Dis 1986;8:1012-23.

9. Ce nte r fo r Dise ase Co ntro l. Cryp to sp o rid io sis: asse ssm e nt o f chemo therapy o f males with acquired immune deficiency syndro me (AIDS). Mo rb Mo rtal Wkly Rep 1982;31:589-92.

10. MacKenzie WR, Ho xie NJ, Pro cto r ME, et al. A massive o utbreak in Milwaukee o f Crypto spo ridium infectio n transmitted thro ugh the public water supply. N Engl J Med 1995;331:161-7.

11. Go ldstein ST, Juranek DD, Ravenho lt O, et al. Crypto spo ridio sis: an o utbreak asso ciated with drinking water despite state-o f-the-art water treatment. Ann Intern Med 1996;124:459-68.

12. Widmer G, Carraway M, Tzipo ri S. Water-bo rne crypto spo ridium: a perspective fro m the USA. Parasito l To day 1996;12:286-90.

13. Co lebunders R, Francis H, Mann JM, et al. Persistent diarrhea, stro ngly asso ciated with HIV infectio n in Kinshasa, Zaire. Am J Gastro entero l 1987;82:859-64.

14. Smith, PD, Lane HC, Gill VJ, et al. Intestinal infectio ns in patients with the acquired immuno deficiency syndro me (AIDS). Ann Intern Med 1988;108:328-33.

15. Dias RMDS, Pinto WP, Chieffi PP, et al. Entero parasito ses em pacientes aco metido s pela síndro me de imuno deficiência adquirida (AIDS/SIDA). Rev Inst Ado lfo Lutz 1988;48:63-7.

16. Ro drigues JLN, Leser P, Silva TMJ, et al. Prevalência da cripto spo ridio se na síndro me diarréica do paciente HIV-po sitivo . Rev Asso c Med Brasil 1991;37:79-84.

17. Cimerman S. Prevalência das parasito ses intestinais em pacientes po rtado res da síndro me da imuno deficiência adquirida. Master’s Dissertation in Infectious and Parasitic Diseases Unit, Universidade Federal do Estado de São Paulo/Escola Paulista de Medicina. São Paulo; 1998:125. 18. Brasil, Ministé rio d a Saúd e . Pro gram a Nac io nal d e DST/AIDS. Asso ciação Brasileira Interdisciplinar de AIDS/(ABIA). Bo l Epidemio l (AIDS) 1988;11:1-41.

19. Baxby D, Hart CA. The incidence o f crypto spo ridio sis: a two year p ro s p e c tive s urve y in a c hild re n’s ho s p ital. J Hyg ( Lo nd o n) 1986;96:107-11.

20. Mo reno A, Gattel JM, Mensa J, et al. Incidencia de entero pató geno s en pacientes co n infecció n po r el vírus de la immuno deficiencia humana. Med Clin (Barc.) 1993;102:205-8.

(7)

alitiasica y crypto spo ridiasis intestinal: asso ciació n frecuente en pacientes VIH. Rev Esp Enferm Dig 1995;87:593-6.

22. Vakil NB, Schwartz SM, Buggy BP, et al. Biliary crypto spo ridio sis in HIV-infected peo ple after the waterbo rne o utbreak o f crypto spo ridio sis in Milwaukee. N Engl J Med 1996;334:19-23.

23. Flannigan T, Whalen C, Turner J, et al. Crypto spo ridium infectio n and CD4 co unts. Ann Intern Med 1992;116:840-2.

24. Casemo re DP, Armstro ng M, Sands RL. Lab o rato ry diagno sis o f crypto spo ridio sis. J Clin Patho l 1985;38:1337-41.

25. Alles AJ, Waldro n MA, Sierra LS, et al. Pro spective co mpariso n o f direct immuno fluo rescence and co nventio nal staining metho ds fo r detectio n o f Giardia and Crypto spo ridium spp. in human fecal specimens. J Clin Micro bio l 1995;33:1632-4.

26. Parisi MT, Tierno Jr PM. Evaluatio n o f new rapid co mmercial enzyme immuno assay fo r detectio n o f Crypto spo ridium o o cysts in untreated sto o l specimens. J Clin Micro bio l 1995;33:1963-5.

27. Marshall MM, Naumo vitz D, Ortega Y, et al. Waterbo rne pro to zo an patho gens. Clin Micro bio l Rev 1997;10:67-85.

28. Ho epelman IM. Human crypto spo ridio sis. Int. J STD & AIDS 1996;7:28-33.

29. Martins CAP, Guerrant RL. Crypto spo ridium and crypto spo ridio sis. Parasito l To day 1995;11:434-6.

30. Hashmey R, Smith NH, Cro n S, et al. Crypto spo ridio sis in Ho usto n, Texas: a repo rt o f 95 cases. Medicine 1997;78:118-39.

31. Uip DE, Lima AL, Amato VS, et al. Ro xithro mycin treatment fo r diarrhea caused by Crypto spo ridium spp. in patients with Aids. J Antimicro b Chemo ther 1998;41(suppl B):93-7

32. Wenyo n CM. Co ccidio sis o f cats and do gs and the status o f the Iso spo ra o f man. Ann Tro p Med Parasito l 1923;17:231-76.

33. So ave R, Jo hnso n WD. Crypto spo ridium and Iso spo ra belli infectio ns. J Infect Dis 1988;157:225-9.

34. De Ho vitz JA, Pape JW, Bo ncy M, et al. Clinical manifestatio ns and therapy o f Is o s p o ra b e lli infe c tio n in p atie nts with the ac q uire d immuno deficiency syndro me. N Engl J Med 1986;315:87-90. 35. Saud a FC, Zam ario li LA, Eb ne r Filho W, e t al. Pre vale nc e o f

Crypto spo ridium sp and Iso spo ra belli amo ng AIDS patients attending Santo s re fe re nce ce nte r fo r Aids, São Paulo , Brazil. J Parasito l 1993;79:454-6.

36. Pape JW, Verdier RI, Jo hnso n Jr WD. Treatment and pro phylaxis o f Iso spo ra belli infectio n in patients with the acquired immuno deficiency syndro me. N Engl J Med 1989;320:1044-7.

37. Benato r DA, French AL, Beaudet LM, et al. Iso spo ra belli infectio n asso ciated with acalculo us cho lecystitis in a patient with AIDS. Ann Intern Med 1994;121:663-4.

38. Restrepo C, Macher AM, Radany EH. Disseminated extraintestinal iso spo riasis in a patient with acquired immune deficiency syndro me. Am J Clin Patho l 1987:87:536-42.

39. Michiels JF, Ho fman P, Bernard E, et al. Intestinal and extraintestinal Iso spo ra belli infectio n in an AIDS patient: a seco nd case repo rt. Patho l Res Pract 1994;190:1089-93.

40. Marcial-Seo ne MA, Serrano -Olmo J. Intestinal infectio n with Iso spo ra belli. P R Health Sci J 1995;14:137-40.

41. Lindsay DS, Bubey JP, Blagbrun BL. Bio lo gy o f Iso spo ra spp. fro m humans, no n-human primates, and do mestic animals. Clin Micro bio l Rev 1997;10:19-34.

42. Ebrahimzadeh A, Bo tto ne EJ. Persistent diarrhea caused by Iso spo ra belli: therapeutic respo nse to pyrimethamine and sulfadiazine. Diagn Micro bio l Infect Dis 1996;26:87-9.

43. Musey KL, Chidiac C, Beacauire G, et al. Effectiveness o f ro xithro mycin fo r treating Iso spo ra belli infectio n. J Infect Dis 1988;158:646. 44. Fo rthall D, Guest SS. Iso spo ra belli enteritis in three ho mo sexual men.

Am J Tro p Med 1984;116:840-2.

45. Bryan RT, We b e r R. Mic ro sc o p o rid ia: e m e rging p atho ge ns in

immuno deficient perso ns. Arch Patho l Lab Med 1993;117:1243-5. 46. Despo rtes I, Charpentier Y, Galian A, et al. Occurrence o f a new

micro spo ridian: Entero cyto zo o n bieneusi n.g. n.s, in the entero cytes o f human patient with AIDS. J Pro to zo o l 1985;32:250-4.

47. Hirs c hfe ld MPM, Cury AE, Mo ura H, e t al. Id e ntific aç ão d e micro spo ridia em 5 pacientes co m AIDS no município de São Paulo . Rev Bras Parasito l Vet 1993;2:95.

48. Mo ura H, Cardo so RR, Velo so VG, et al. Micro spo ridia e diarréia crô nica em AIDS: identificação de entero cyto zo o n em 2 pacientes no Rio de Janeiro . In: Co ngresso da So ciedade Brasileira de Medicina Tro pical – Resumo s, Fo rtaleza, 1993;180.

49. Brasil P, So dré FC, Cuzzi T, et al. Micro spo ridio se intestinal: estudo de 6 pacientes HIV-po sitivo s no Rio de Janeiro . Rev So c Bras Med Tro p 1994;27(suppl1):145.

50. Wuhib T, Silva TMJ, Newman RD. Crypto spo ridial and micro spo ridial infectio ns in human immuno deficiency virus-infected patients in no rtheastern Brazil. J Infect Dis 1994;170:490-7.

51. Weber R, Bryan RT. Micro spo ridial infectio ns in immuno deficient and immuno co mpetent patients. Clin Infect Dis 1994;19:517-22.

52. So dré FC. Micro spo ridio sis humanas: desenvo lvimento de méto do s para diagnó stico mo rfo ló gico das micro spo ridio ses intestinais em pacientes HIV-po sitivo s no município do Rio de Janeiro . Master Dissertatio n, Fundação Instituto Oswaldo Cruz. Rio de Janeiro ; 1996. 52. De Paula Amato JG. Aplicação de méto do mo dificado de co lo ração tric rô m ic a, e m fe ze s d iarré ic as d e infe c tad o s p e lo HIV, p ara pesq uisa de micro spo rídio s. Master dissertatio n. Faculdade de Medicina da Universidade de São Paulo ;1998:74.

53. Weber R, Bryan RT, Ownen RL, et al. Impro ved light-micro sco pical detectio n o f micro spo ridia spo res in sto o l and duo denal aspirates. N Engl J Med 1992;326:161-6.

54. Mo ura H, Da Silva JL, So dre FC, et al. Gram-chro mo tro pe: a new technique that enhances detectio n o f micro spo ridial spo res in clinical samples. J Eukaryo t Micro bio l 1996;43:94S-95S.

55. Blanshard C, Ellis DS, To ve y DG, e t al. Tre atme nt o f inte stinal micro spo ridio sis with alb e ndazo le in patie nts with AIDS. AIDS 1992;6:331-3.

56. Dietrich DT. Lew EA, Ko tler DP, et al. Treatment with albendazo l fo r intestinal disease due to Entero cyto zo o n bieneusi in patient with AIDS. J Infect Dis 1994;169:178-83.

57. Mo lina JM, Okse nhe nd le r E, Be auvais B, e t al. Disse m inate d micro spo ridio sis due to Septata intestinalis in patients with AIDS: clinical features and respo nse to albendazo le therapy. J Infect Dis 1995;171:245-9.

58. Cunningham AL, Gro hman GS, Harkness J, et al. Gastro intestinal viral infectio ns in ho mo sexual men who were sympto matic and sero po sitive fo r human deficiency virus. J Infect Dis 1988;157:386-91.

59. Markell EK, Havens RF, Kuritsubo RA, et al. Intestinal pro to zo a in ho mo sexual men o f the San Francisco Bay area: prevalence and co rrelates o f infectio n. Am J Tro p Med Hyg 1984;33:239-45.

60. Allaso n-Jo nes E, Mindell A, Sargeaunt P, et al. Entamo eba histo lytica as a co mmensal intestinal parasite in ho mo sexual men. N England J Med 1986;315:353-6.

61. Esfandiari A, Jo rdan WC, Bro wn CP. Prevalence o f enteric parasitic infectio n amo ng HIV-infected attendees o f an inner city AIDS clinic. Cell Mo l Bio l 1995;41:519-23.

62. Co tte L, Rabo do rina M, Piens MP, et al. Prevalence in intestinal pro to zo ans in French patients infected with HIV. J Acquir Immune Defic Syndr 1993;6:1024-9.

63. Mendez OC, Szmulewicz G, Menghi C, et al. Co mparacio n de indices de infestacio nes po r entero parasito s entre po blacio nes HIV- po sitivas y negativas. Medicina (Bueno s Aires) 1994;54:307-10.

64. Guerin JM, Ho ang C, Galian A, et al. Severe diarrhea in a patient with AIDS. J Am Med Asso c 1986;256:591.

(8)

prevalence o f invasive amebiasis is no t increased in patients with AIDS. AIDS 1992;6:307-9.

66. Alencar LCA, Magalhães V, Melo VM, et al. Ausência de amebíase invasiva em aidético s ho mo ssexuais masculino s, em Recife. Rev So c Bras Med Tro p 1996;29:319-22.

67. Mahmo ud AAF. Stro ngylo idiasis. Clin Infect Dis 1996;23:949-53. 68. Devault Jr GA, King JW, Ro hr MS, et al. Oppo rtunistic infectio ns with

Stro ngylo ides sterco ralis in renal transplantatio n. Rev Infect Dis 1990;12:653-71.

69. Dias RMDS, Mangini ACS, To rre s DMAGV, e t al. Oco rrê ncia de Stro ngylo ides sterco ralis em pacientes po rtado res da síndro me de imuno deficiência adquirida (AIDS). Rev Inst Med Tro p 1992;34:15-7. 70. Celedo n JC, Mathur-Wagh V, Fo x J, et al. Systemic stro ngilo idiasis in

patients infected with the human immuno deficiency virus. Medicine 1994;73:256-63.

71. Levi GC, Kallás EG, Leite KRM. Disseminated Stro ngylo ides sterco ralis infectio n in an AIDS patient: the ro le o f suppressive therapy. Braz J Infect Dis 1997;1:48-51.

72. Wo ng B. Parasitic diseases in immuno co mpro mised ho sts. Am J Med 1984;76:479-85.

73. Del Carpio D, Ro dríguez D, Vildó so la H. Síndro me de hiperinfecció n po r Stro ngylo ides sterco ralis en una paciente co n infecció n po r el vírus de la immuno deficiencia humana (VIH): repo rte de un caso y revisió n de la literatura. Rev Gastro entero l Peru 1995;15:290-5.

74. Sarangarajan R, Belmo nte AH, Tchertko ff V. Stro ngylo ides sterco ralis hyperinfectio n diagno sed by gastric cyto lo gy in an AIDS patients. AIDS 1997;11:394-5.

75. Ferreira MS, Nishio ka SA, Bo rges AS, et al. Stro ngylo idiasis and infectio n due to human immuno deficiency virus: 25 cases at a Brazilian teaching ho spital, including seven cases o f hyperinfectio n syndro me. Clin Inf Dis 1999;28:154-55

76. To rres JR, Isturiz R, Murillo J, et al. Efficacy o f ivermectin in the treatment o f stro ngylo idiasis co mplicating AIDS. Clin Inf Dis 1993;17:900-2. 77. Stenzel DJ, Bo reham PFL. Blasto cystis ho minis revisited. Clin Micro bio l

Rev 1996;9:563-84.

78. Jo nes TC. Blasto mycys ho minis: mo re than 70 years o f debate regarding patho genicity. Braz J Infect Dis 1997;1:102-3.

79. El Masry NA, Bassily S, Farid Z, et al. Po tential clinical significance o f Blasto cystis ho minis in Egypt. Trans R So c Tro p Med Hyg 1990;84:695. 80. Garavelli PL, So aglio ne L, Libano re M, et al. Blasto cystis: a new disease

in patients with leukemia. Haemato lo gica 1991;76:80.

81. Brites C, Barberino MG, Basto s MA, Silva N. Blasto cystis ho minis as a po tential cause o f diarrhea in AIDS patients: a repo rt o f six cases in Bahia, Brazil. Braz J Infect Dis 1997;1:91-4.

82. Lee MJ. Patho genicity o f Blasto mycia ho minis. J Clin Micro b io l 1991;29:2089.

83. Zaman V. The diagno sis o f Blasto cystis ho minis in human feces. J Infect 1996;33:15-6.

84. Garavelli PL, Libano re M. Blasto cystis in immuno deficiency diseases. Rev Infect Dis 1990;12:158.

85. Hart AS, Ridinger MT, Oundarajan R, et al. No vel o rganism asso ciated with chro nic diarrhea in AIDS. Lancet 1990;335:169-70.

86. Brenan MK, McPherso n DW, Palmer J, et al. Cyclo spo riasis: a new cause a diarrhea. Can Med Asso c J 1996;155:1293-6.

87. So ave R. Cyclo spo ra: an o verview. Clin Infect Dis 1996;23:429-37. 88. Herwaldt BL, Ackers ML, Cyclo spo ra Wo rking Gro up. An o utbreak in

1996 o f cyclo spo riasis asso ciated with impo rted raspberries. N Engl J Med 1997;336:1548-56.

89. Centers fo r Disease Co ntro l and Preventio n. Outbreak o f cyclo spo riasis, no rthern Virginia, Washingto n, D.C., Baltimo re, Maryland, Metro po litan Area, 1997. Mo rb Mo rtal Wkly Rep 1997;46:689-91.

90. Mannheimer SB, So ave R. Pro to zo al infectio ns in patients with AIDS. Infect Dis Clin No rth Am 1994;8:483-97.

91. Pape JW, Verdier RI, Bo ncy M, et al. Cyclo spo ra infectio n in adults infected with HIV: clinical manifestatio ns, treatment and pro phylaxis. Ann Intern Med 1994;121:654-7.

92. Go o dgame RW. Understanding intestinal spo re-fo rming pro to zo a: crypto spo ridia, micro spo ridia, iso spo ra, and cyclo spo ra. Ann Intern Med 1996;124:429-41.

Sérgio Cimerma n - MD. Instituto de Infecto lo gia Emílio Ribas and Esco la Paulista de Medicina, Univerisidade Federal de São Paulo . São Paulo , Braz il.

Benja min Cimerma n - Parasito lo gy Department, University o f Mo gi das Cruzes. Mo g i das Cruz es, Braz il.

Da vid Sa lomã o Lew i- MD, PhD. Infectio us and Parasitic Diseases Unit, Universidade Federal de São Paulo / Esco la Paulista de Medicina. São Paulo , Braz il.

Sources of funding: No t declared

Conflict of interest: No t declared

La st received: 1 9 March 1 9 9 9

Accepted: 7 April 1 9 9 9

Address for correspondence:

Sérgio Cimerman

Alameda Jauaperí, 8 9 0 - Apto . 1 1 1 São Paulo / SP - Brasil - CEP 0 4 5 2 3 -0 1 4 E-mail: sc@ mandic.co m.br

RESUMO

O BJETIVO : Relatar a impo rtância das parasito ses intestinais em pacientes co m Aids, mo strando dado s relevantes na literatura médica, co m enfo que em especial, abo rdando a epidemio lo g ia, diag nó stico e tratamento das entero parasito ses, principalmente da cripto spo ridíase, iso spo ríase, micro spo ridíase e estro ng ilo idíase. TIPO DE ESTUDO : Revisão narrativa.

Referências

Documentos relacionados

the present study, we describe a cross-sectional study of enteric infection in 40 AIDS patients in Rio de Janeiro, to ascertain the prevalence of intestinal infection either in

O aparecimento das HD traumáticas, geralmente num contexto de múltiplos e graves traumatismos, constituem geral- mente casos de grande urgência com insuficiência respiratória

The remaining 89 patients exhibited 36 cases of opportunistic infections alone, seven cases of Kaposi’s sarcoma alone, 10 cases of Kaposi’s sarcoma associated..

In the case of relux samples presenting the phase mixture, the N doping in brookite enhanced the photocatalytic activity in UV and visible light when compared to samples containing

Altered z inc and co pper co ncentratio ns in the plasma o r serum have been previo usly repo rted in cancer patients.. Re missio n is usua lly asso ciated with the return o f

The development of the procedure starts by identifying problems, setting goals and objectives to be achieved, research literature in maintenance area and best

study revealed an even higher proportion; half (9/19, 47.4%) of immunocompetent patients with pulmonary cryptococco- sis were asymptomatic, and their disease was incidentally

The study was conducted at two AIDS Outpatient Clinics in Brazil: AIDS Outpatient Clinic, São Bernardo do Campo, São Paulo, Bra- zil (SBC) and AIDS Outpatient Clinic of Faculdade